These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 22147937)

  • 41. EGFR: a prognostic and/or a predictive marker?
    Hirsch FR
    J Thorac Oncol; 2006 Jun; 1(5):395-7. PubMed ID: 17409888
    [No Abstract]   [Full Text] [Related]  

  • 42. microRNA and Lung Cancer.
    Del Vescovo V; Denti MA
    Adv Exp Med Biol; 2015; 889():153-77. PubMed ID: 26659001
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular analysis-based treatment strategies for the management of non-small cell lung cancer.
    West H; Lilenbaum R; Harpole D; Wozniak A; Sequist L
    J Thorac Oncol; 2009 Sep; 4(9 Suppl 2):S1029-39; quiz S1041-2. PubMed ID: 19704347
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNA-187-5p suppresses cancer cell progression in non-small cell lung cancer (NSCLC) through down-regulation of CYP1B1.
    Mao M; Wu Z; Chen J
    Biochem Biophys Res Commun; 2016 Sep; 478(2):649-55. PubMed ID: 27495872
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The oncomiR miR-197 is a novel prognostic indicator for non-small cell lung cancer patients.
    Mavridis K; Gueugnon F; Petit-Courty A; Courty Y; Barascu A; Guyetant S; Scorilas A
    Br J Cancer; 2015 Apr; 112(9):1527-35. PubMed ID: 25867273
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gene mutation analysis in non-small cell lung cancer patients using bronchoalveolar lavage fluid and tumor tissue as diagnostic markers.
    Li J; Hu YM; Wang Y; Tang XP; Shi WL; Du YJ
    Int J Biol Markers; 2014 Dec; 29(4):e328-36. PubMed ID: 24519547
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictive Significance of Thymidylate Synthase Expression in Non-small Cell Lung Cancer.
    Kulda V; Hrda K; Houdek Z; Dobra JK; Vrzakova R; Svaton M; Safranek J; Dolezal J; Babuska V; Pesek M; Topolcan O; Pesta M
    Anticancer Res; 2017 Dec; 37(12):6953-6958. PubMed ID: 29187479
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Retinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer.
    Huang Q; Fan J; Qian X; Lv Z; Zhang X; Han J; Wu F; Chen C; Du J; Guo M; Hu G; Jin Y
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):263-72. PubMed ID: 26319393
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of the NEDD4L gene as a prognostic marker by integrated microarray analysis of copy number and gene expression profiling in non-small cell lung cancer.
    Sakashita H; Inoue H; Akamine S; Ishida T; Inase N; Shirao K; Mori M; Mimori K
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S590-8. PubMed ID: 23812770
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic impact of Bcl-2 depends on tumor histology and expression of MALAT-1 lncRNA in non-small-cell lung cancer.
    Schmidt LH; Görlich D; Spieker T; Rohde C; Schuler M; Mohr M; Humberg J; Sauer T; Thoenissen NH; Huge A; Voss R; Marra A; Faldum A; Müller-Tidow C; Berdel WE; Wiewrodt R
    J Thorac Oncol; 2014 Sep; 9(9):1294-304. PubMed ID: 25036876
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Copine 3 as a Novel Potential Drug Target for Non-Small-Cell Lung Carcinoma.
    Sakthivel KM; Prabhu VV
    J Environ Pathol Toxicol Oncol; 2017; 36(2):107-112. PubMed ID: 29199591
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Can the response to a platinum-based therapy be predicted by the DNA repair status in non-small cell lung cancer?
    Macerelli M; Ganzinelli M; Gouedard C; Broggini M; Garassino MC; Linardou H; Damia G; Wiesmüller L
    Cancer Treat Rev; 2016 Jul; 48():8-19. PubMed ID: 27262017
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Imaging and genomics: is there a synergy?
    Jaffe CC
    Radiology; 2012 Aug; 264(2):329-31. PubMed ID: 22821693
    [No Abstract]   [Full Text] [Related]  

  • 54. Prognostic value of LIPC in non-small cell lung carcinoma.
    Alifano M; Damotte D
    Cell Cycle; 2013 Feb; 12(4):543-4. PubMed ID: 23370388
    [No Abstract]   [Full Text] [Related]  

  • 55. Non-mutational (epigenomic) structural variation in the transcriptome of cancer cells.
    Thompson EA
    Oncotarget; 2015 Feb; 6(6):3473-4. PubMed ID: 25704887
    [No Abstract]   [Full Text] [Related]  

  • 56. Seeing the Forest through the Phylogenetic Tree.
    Robles AI; Zenklusen JC
    N Engl J Med; 2017 Jun; 376(22):2190-2191. PubMed ID: 28564575
    [No Abstract]   [Full Text] [Related]  

  • 57. Immune Signatures of Non-Small Cell Lung Cancer.
    Green S; Dawe DE; Banerji S
    J Thorac Oncol; 2017 Jun; 12(6):913-915. PubMed ID: 28532560
    [No Abstract]   [Full Text] [Related]  

  • 58. Application of the Lung Immune Prognostic Index From Research to Clinical Practice.
    Long J; Lin J; Zhao H
    JAMA Oncol; 2020 Feb; 6(2):299-300. PubMed ID: 31774467
    [No Abstract]   [Full Text] [Related]  

  • 59. Application of the Lung Immune Prognostic Index From Research to Clinical Practice-Reply.
    Kazandjian D; Gong Y; Blumenthal GM
    JAMA Oncol; 2020 Feb; 6(2):300-301. PubMed ID: 31774473
    [No Abstract]   [Full Text] [Related]  

  • 60. Sequencing cells of the immune TME.
    Killock D
    Nat Rev Clin Oncol; 2018 Sep; 15(9):531. PubMed ID: 29985469
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.